| Peer-Reviewed

Feasibility of Applying Novel FDP Threshold Criteria to DIC Diagnostic Scoring Systems in Japanese Women with Placental Abruption

Received: 6 April 2022    Accepted: 20 April 2022    Published: 29 April 2022
Views:       Downloads:
Abstract

Objective: The diagnosis of disseminated intravascular coagulation (DIC) in obstetrics characterized by marked elevation of fibrin/fibrinogen degradation products (FDP) requires specific FDP criteria, however, no reference values are currently available. We previously reported the FDP criteria reflecting the degree of coagulation activity, determined by the quantitative relation between the distributions of FDP and fibrinogen. We aimed to evaluate the feasibility of applying the novel FDP criteria to four existing DIC diagnostic scoring systems, in a retrospective study of Japanese women with placental abruption. Materials and Methods: The study population was 68 pregnant women who had been diagnosed with placental abruption at Okayama Medical Center (Japan) between January 2008 and December 2020. DIC was clinically determined using the following four categories: plasma fibrinogen level < 100 mg/dl, hemorrhage amount at delivery ≥ 2000 g, blood product (red blood cells and fresh frozen plasma) transfusion, and renal dysfunction. Based on our previous report on the artificial intelligence analysis of the FDP distribution function, FDP criteria for the normal upper limit, moderate increase, and marked increase were defined as 20, 32, and 80 μg/ml, respectively. We applied the FDP criteria to compare four current and revised DIC diagnostic scoring systems: Japanese Ministry of Health and Welfare (JMHW), Japanese Association for Acute Medicine (JAAM), International Society on Thrombosis and Haemostasis (ISTH), and pregnancy-modified ISTH (PM-ISTH) DIC score. We used the Kruskal-Wallis test, Wilcoxon rank-sum test, and proportion test for statistical analysis. Results: Clinical DIC was observed in nine cases. Sensitivity was 1.00 in all DIC scoring systems. The current/revised sensitivity of the JMHW, JAAM, ISTH, and PM-ISTH systems was 1.00/1.00, 1.00/1.00, not available (NA)/1.00, and 1.00/NA, respectively. The current/revised specificity of the JMHW, JAAM, ISTH, and PM-ISTH systems was 0.864/0.864, 0.678/0.797, NA/0.864, and 0.424/NA, respectively. The specificity of the revised JMHW and revised ISTH systems was higher than for the current JAAM (P < 0.05) and current PM-ISTH (P < 0.0001) systems. The specificity of the revised JAAM improved from 0.678 to 0.797. Conclusion: Our novel proposed FDP criteria are potentially useful for diagnosis of DIC in placental abruption.

Published in European Journal of Clinical and Biomedical Sciences (Volume 8, Issue 2)
DOI 10.11648/j.ejcbs.20220802.14
Page(s) 27-32
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Diagnostic Tests, Disseminated Intravascular Coagulation, Fibrin Fibrinogen Degradation Products, Fibrinolysis, Placental Abruption

References
[1] Levi M, Toh CH, Thachil J, Watson HG. (2009). Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 145 (1), 24-33.
[2] Levi M. (2013). Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thromb Res. 131, 32-34.
[3] Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). (2001). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 86 (5), 1327-1330.
[4] Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. (1983). Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the research committee on DIC in Japan. Bibl Haematol. 49, 265-275.
[5] Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group, et al. (2006). A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 34 (3), 625-631.
[6] Wada H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, et al. (2017). The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 15, 17. doi: 10.1186/s12959-017-0142-4.
[7] Terao T, Maki M, Ikenoue T. (1987). A prospective study in 38 patients with abruptio placentae of 70 cases complicated by DIC. Asia Oceania J Obstet Gynaecol. 13 (1), 1-13.
[8] Erez O, Novack L, Beer-Weisel R, Dukler D, Press F, Zlotnik A, et al. (2014). DIC score in pregnant women – A population based modification of the International Society on Thrombosis and Hemostasis score. PLoS One. 11, 9 (4). e93240. doi: 10.1371/journal.pone.0093240.
[9] Asakura H. (2014). Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care. 2 (1), 20. doi: 10.1186/2052-0492-2-20.
[10] Asakura H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, et al. (2016). Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 14, 42. doi: 10.1186/s12959-016-0117-x.
[11] Collins P, Abdul-Kadir R, Thachil J. (2016). Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost. 14 (1), 205-210.
[12] Miyagi Y, Tada K, Yasuhi I, Maekawa Y, Okura N, Kawakami K, et al. (2020). New method for determining fibrinogen and FDP threshold criteria by artificial intelligence in cases of massive hemorrhage during delivery. J Obstet Gynaecol Res. 46 (2), 256-265.
[13] Tada K, Miyagi Y, Yasuhi I, Yoshida M, Yorozu M, Maegawa Y, et al. (2020). Clinical features of dilutional coagulopathy in massive obstetrical hemorrhage: A multicenter retrospective case series study. J Jpn Soc Perin Neon Med. 56 (3), 417-423.
[14] Rattray DD, O’Connell CM, Basket TF. (2012). Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can. 34 (4), 341-347.
[15] Collis RE, Collins PW. (2015). Haemostatic management of obstetric haemorrhage. Anaesthesia. 70 (Suppl. 1), 78-86.
[16] Stratta P, Canavese C, Colla L, Dogliani M, Messina M, Gabella P, et al. (1986). Acute renal failure in obstetric complications. Biol Res Pregnancy Perinatol. 7 (3), 113-117.
[17] Mahmoodian S. (1989). DIC and acute renal failure as a complication of abruptio placentae. W V Med J. 85 (12), 527-530.
[18] Thachil J, Toh CH. (2009). Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev. 23 (4), 167-176.
[19] Madoiwa S. (2015). Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC. J Intensive Care. 3, 8. doi: 10.1186/s40560-015-0075-6.
[20] Wang W, Long K, Deng F, Ye W, Zhang P, Chen X, et al. (2021). Changes in levels of coagulation parameters in different trimesters among Chinese pregnant women. J Clin Lab Anal. 35 (4), e23724. doi: 10.1002/jcla.23724.
[21] Bonnar J, Davidson JF, Pidgeon CF, McNicol GP, Douglas AS. (1969). Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J. 3, 137-140.
[22] American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 20 (6), 864-874.
[23] Saftlas AF, Olson DR, Atrash HK, Rochat R, Rowley D. (1991). National trends in the incidence of abruptio placentae, 1979-1987. Obstet Gynecol. 78 (6), 1081-1086.
[24] Sher G. (1977). Pathogenesis and management of uterine inertia complicating abruptio placentae with consumptive coagulopathy. Am J Obstet Gynecol. 129 (2), 164-170.
[25] Letsky EA. (2001). Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol. 15 (4), 623-644.
Cite This Article
  • APA Style

    Katsuhiko Tada, Yasunari Miyagi, Kazumasa Kumazawa, Saya Tsukahara, Naoki Okimoto, et al. (2022). Feasibility of Applying Novel FDP Threshold Criteria to DIC Diagnostic Scoring Systems in Japanese Women with Placental Abruption. European Journal of Clinical and Biomedical Sciences, 8(2), 27-32. https://doi.org/10.11648/j.ejcbs.20220802.14

    Copy | Download

    ACS Style

    Katsuhiko Tada; Yasunari Miyagi; Kazumasa Kumazawa; Saya Tsukahara; Naoki Okimoto, et al. Feasibility of Applying Novel FDP Threshold Criteria to DIC Diagnostic Scoring Systems in Japanese Women with Placental Abruption. Eur. J. Clin. Biomed. Sci. 2022, 8(2), 27-32. doi: 10.11648/j.ejcbs.20220802.14

    Copy | Download

    AMA Style

    Katsuhiko Tada, Yasunari Miyagi, Kazumasa Kumazawa, Saya Tsukahara, Naoki Okimoto, et al. Feasibility of Applying Novel FDP Threshold Criteria to DIC Diagnostic Scoring Systems in Japanese Women with Placental Abruption. Eur J Clin Biomed Sci. 2022;8(2):27-32. doi: 10.11648/j.ejcbs.20220802.14

    Copy | Download

  • @article{10.11648/j.ejcbs.20220802.14,
      author = {Katsuhiko Tada and Yasunari Miyagi and Kazumasa Kumazawa and Saya Tsukahara and Naoki Okimoto and Mizuho Yoshida and Naomi Ooka},
      title = {Feasibility of Applying Novel FDP Threshold Criteria to DIC Diagnostic Scoring Systems in Japanese Women with Placental Abruption},
      journal = {European Journal of Clinical and Biomedical Sciences},
      volume = {8},
      number = {2},
      pages = {27-32},
      doi = {10.11648/j.ejcbs.20220802.14},
      url = {https://doi.org/10.11648/j.ejcbs.20220802.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejcbs.20220802.14},
      abstract = {Objective: The diagnosis of disseminated intravascular coagulation (DIC) in obstetrics characterized by marked elevation of fibrin/fibrinogen degradation products (FDP) requires specific FDP criteria, however, no reference values are currently available. We previously reported the FDP criteria reflecting the degree of coagulation activity, determined by the quantitative relation between the distributions of FDP and fibrinogen. We aimed to evaluate the feasibility of applying the novel FDP criteria to four existing DIC diagnostic scoring systems, in a retrospective study of Japanese women with placental abruption. Materials and Methods: The study population was 68 pregnant women who had been diagnosed with placental abruption at Okayama Medical Center (Japan) between January 2008 and December 2020. DIC was clinically determined using the following four categories: plasma fibrinogen level Results: Clinical DIC was observed in nine cases. Sensitivity was 1.00 in all DIC scoring systems. The current/revised sensitivity of the JMHW, JAAM, ISTH, and PM-ISTH systems was 1.00/1.00, 1.00/1.00, not available (NA)/1.00, and 1.00/NA, respectively. The current/revised specificity of the JMHW, JAAM, ISTH, and PM-ISTH systems was 0.864/0.864, 0.678/0.797, NA/0.864, and 0.424/NA, respectively. The specificity of the revised JMHW and revised ISTH systems was higher than for the current JAAM (P P Conclusion: Our novel proposed FDP criteria are potentially useful for diagnosis of DIC in placental abruption.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Feasibility of Applying Novel FDP Threshold Criteria to DIC Diagnostic Scoring Systems in Japanese Women with Placental Abruption
    AU  - Katsuhiko Tada
    AU  - Yasunari Miyagi
    AU  - Kazumasa Kumazawa
    AU  - Saya Tsukahara
    AU  - Naoki Okimoto
    AU  - Mizuho Yoshida
    AU  - Naomi Ooka
    Y1  - 2022/04/29
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ejcbs.20220802.14
    DO  - 10.11648/j.ejcbs.20220802.14
    T2  - European Journal of Clinical and Biomedical Sciences
    JF  - European Journal of Clinical and Biomedical Sciences
    JO  - European Journal of Clinical and Biomedical Sciences
    SP  - 27
    EP  - 32
    PB  - Science Publishing Group
    SN  - 2575-5005
    UR  - https://doi.org/10.11648/j.ejcbs.20220802.14
    AB  - Objective: The diagnosis of disseminated intravascular coagulation (DIC) in obstetrics characterized by marked elevation of fibrin/fibrinogen degradation products (FDP) requires specific FDP criteria, however, no reference values are currently available. We previously reported the FDP criteria reflecting the degree of coagulation activity, determined by the quantitative relation between the distributions of FDP and fibrinogen. We aimed to evaluate the feasibility of applying the novel FDP criteria to four existing DIC diagnostic scoring systems, in a retrospective study of Japanese women with placental abruption. Materials and Methods: The study population was 68 pregnant women who had been diagnosed with placental abruption at Okayama Medical Center (Japan) between January 2008 and December 2020. DIC was clinically determined using the following four categories: plasma fibrinogen level Results: Clinical DIC was observed in nine cases. Sensitivity was 1.00 in all DIC scoring systems. The current/revised sensitivity of the JMHW, JAAM, ISTH, and PM-ISTH systems was 1.00/1.00, 1.00/1.00, not available (NA)/1.00, and 1.00/NA, respectively. The current/revised specificity of the JMHW, JAAM, ISTH, and PM-ISTH systems was 0.864/0.864, 0.678/0.797, NA/0.864, and 0.424/NA, respectively. The specificity of the revised JMHW and revised ISTH systems was higher than for the current JAAM (P P Conclusion: Our novel proposed FDP criteria are potentially useful for diagnosis of DIC in placental abruption.
    VL  - 8
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Obstetrics and Gynecology, National Hospital Organization, Okayama Medical Center, Okayama, Japan

  • Medical Data Labo, Okayama, Japan

  • Department of Obstetrics and Gynecology, National Hospital Organization, Okayama Medical Center, Okayama, Japan

  • Department of Obstetrics and Gynecology, National Hospital Organization, Okayama Medical Center, Okayama, Japan

  • Department of Obstetrics and Gynecology, National Hospital Organization, Okayama Medical Center, Okayama, Japan

  • Department of Obstetrics and Gynecology, National Hospital Organization, Okayama Medical Center, Okayama, Japan

  • Department of Obstetrics and Gynecology, National Hospital Organization, Okayama Medical Center, Okayama, Japan

  • Sections